Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Ferring Pharmaceuticals, Rebiotix, (a Ferring company), and MyBiotics Pharma have announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a...
Quantum-Si, a startup founded by Guilford bioscience entrepreneur Jonathan Rothberg, is going public through a merger with HighCape Capital Acquisition Corp. in a deal that values the...
DNSK International reports approval of UKONIQTM (aka Umbralisib, TGR1202, RP-5264) for the treatment of marginal zone lymphoma and follicular lymphoma. Since 2010 DNSK has been working...
One of the larger undeveloped parcels in Windsor’s Great Pond business park may soon be transformed into a major biotech research and development hub. The...
UConn’s Technology Incubation Program (TIP) is expanding to Stamford with a new location focused on data science startups … more Technology Commercialization Services’ (TCS) Mostafa...
Connecticut Innovations (CI), Connecticut’s strategic venture capital arm, has announced an effort to promote Connecticut’s life sciences ecosystem. The effort, “Connecticut: Where Science Lives,” highlights the...
Cybrexa Therapeutics has completed the GLP toxicology study of its lead candidate, CBX-12. The positive results for this study serve as a guide for dosing...
Following Connecticut Governor Ned Lamont’s budget address to members of the General Assembly, BioCT’s President and CEO, Dawn Hocevar, issued the following statement. Imposing arbitrary...
Bristol Myers Squibb has secured global rights to a pair of anti-SARS-CoV-2 antibodies discovered by The Rockefeller University. The antibodies entered phase 1 development last...
Sema4 and CM Life Sciences have entered into a definitive business combination agreement. Upon closing, CM Life Sciences will be renamed and its common stock...